Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network

Mechanisms-of-resistance to decitabine and 5-azacytidine, mainstay treatments for myeloid malignancies, require investigation and countermeasures. Both are nucleoside analog pro-drugs processed by pyrimidine metabolism into a deoxynucleotide analog that depletes the key epigenetic regulator DNA meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaorong, Tohme, Rita, Tomlinson, Benjamin, Sakre, Nneha, Hasipek, Metis, Durkin, Lisa, Schuerger, Caroline, Grabowski, Dale, Zidan, Asmaa M., Radivoyevitch, Tomas, Hong, Changjin, Carraway, Hetty, Hamilton, Betty, Sobecks, Ronald, Patel, Bhumika, Jha, Babal K., Hsi, Eric D., Maciejewski, Jaroslaw, Saunthararajah, Yogen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867667/
https://www.ncbi.nlm.nih.gov/pubmed/32770088
http://dx.doi.org/10.1038/s41375-020-1003-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867667/
https://www.ncbi.nlm.nih.gov/pubmed/32770088
http://dx.doi.org/10.1038/s41375-020-1003-x

Ejemplares similares